Diagnos Inc., a leader in diabetic retinopathy screening and healthcare technical services, intends to screen 5 million people in Madhya Pradesh for diabetic retinopathy (a disease of the eye that usually hits people with diabetes).
The company has signed a MoU with the Government of Madhya Pradesh, under which the Government would facilitate Diagnos’ work.
“This MoU assures us that the Government will promote and support our efforts to offer DR screening services to the estimated 5 million people with diabetes in the State. With the support of local authorities, we plan to begin to implement mobile screening units to cover some of the 1,100 primary health centres and 8,800 sub-centres. We have already begun putting into place the necessary agreements with local healthcare providers to treat patients with positive screening results.’’
“If the pledged Government support materialises under this MoU, and agreements with local healthcare providers proceed as planned, our present objective is to screen between 100,000 and 200,000 diabetic patients in the state in 2013, and expand from there,’’ says a press release of Diagnos.
Founded in 1998, Diagnos is a publicly traded Canadian corporation with a “mission to commercialise technologies combining contextual imaging and traditional data mining thereby improving decision-making processes.”
Diagnos offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources.